Latest Trials Latest NewsFAQ

BAYLOR COLLEGE OF MEDICINE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1900-10-30

Employees: 10K

Market Cap: -

Website: http://www.bcm.edu

Clinical Trials

Glutathione and Function in HIV Patients

Phase 1

Completed

Conditions: HIV Infection
Erythrocyte Glutathione Deficiency

Interventions: Dietary Supplement: GlyNAC (combination of glycine and n-acetylcysteine)

First Posted Date: 2015-01-28

Last Posted Date: 2021-02-21

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 16

Registration Number: NCT02348775

Locations: 🇺🇸
Baylor Metabolic Research Unit (MRU), Houston, Texas, United States

Lifestyle Intervention for Senior Diabetics

Not Applicable

Completed

Conditions: Overweight
Aging
Diabetes Mellitus

Interventions: Behavioral: Healthy lifestyle
Behavioral: Weight loss and Exercise

First Posted Date: 2015-01-28

Last Posted Date: 2021-01-14

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 100

Registration Number: NCT02348801

Locations: 🇺🇸
Michael E DeBakey VA Medical Center, Houston, Texas, United States

Energetics and Function in Older Humans

Phase 1

Completed

Conditions: Aging
Erythrocyte Glutathione Deficiency
Muscle Weakness

Interventions: Dietary Supplement: Cysteine (as n-acetylcysteine) and Glycine

First Posted Date: 2015-01-28

Last Posted Date: 2022-02-11

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 16

Registration Number: NCT02348762

Locations: 🇺🇸
Baylor Metabolic Research Unit (MRU), Houston, Texas, United States

Treatment of Hemoglobin SC Disease With Hydroxyurea

Phase 2

Terminated

Conditions: Hemoglobin SC Disease

Interventions: Drug: hydroxyurea

First Posted Date: 2015-01-13

Last Posted Date: 2020-09-09

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 32

Registration Number: NCT02336373

Locations: 🇺🇸
Texas Children's Hospital, Houston, Texas, United States

Ceftaroline for Treatment of Hematogenously Acquired Staphylococcus Aureus Osteomyelitis in Children

Phase 1

Completed

Conditions: Hematogenously Acquired Staphylococcus Aureus Osteomyelitis
Bone Infection
Osteomyelitis

Interventions: Drug: Ceftaroline Fosamil

First Posted Date: 2015-01-12

Last Posted Date: 2021-11-02

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 11

Registration Number: NCT02335905

Locations: 🇺🇸
Texas Children's Hospital, Houston, Texas, United States

A Pilot Study To Evaluate The Preliminary Safety And Feasibility Of The Materna Medical Device

Not Applicable

Completed

Conditions: Tear, Pelvic Organ, Obstetric Trauma

Interventions: Device: Materna Medical

First Posted Date: 2015-01-07

Last Posted Date: 2020-08-06

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 61

Registration Number: NCT02332759

Locations: 🇺🇸
Texas Children's Hospital Pavilion For Women, Houston, Texas, United States

Saving Lives at Birth: Primary Prevention of Periodontal Disease in Relation to Preterm Birth in Malawi

Not Applicable

Completed

Conditions: Preterm Birth
Periodontal Disease
Caries, Dental

Interventions: Dietary Supplement: Xylitol gum

First Posted Date: 2015-01-07

Last Posted Date: 2024-01-08

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 10069

Registration Number: NCT02333227

Locations: 🇺🇸
Baylor College of Medicine, Houston, Texas, United States

Tranexamic Acid in Adherent Placenta (TAP)

Phase 3

Withdrawn

Conditions: Placenta Accreta

Interventions: Drug: Tranexamic Acid (TXA)
Drug: Sodium Chloride 0.9%

First Posted Date: 2015-01-01

Last Posted Date: 2018-08-23

Lead Sponsor: Baylor College of Medicine

Registration Number: NCT02329756

Locations: 🇺🇸
Baylor College of Medicine, Houston, Texas, United States

Standardized Prenatal Clinical Care for LUTO

Recruiting

Conditions: Urethral Obstruction

Interventions: Procedure: Fetal Intervention for LUTO

First Posted Date: 2014-12-12

Last Posted Date: 2024-10-24

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 50

Registration Number: NCT02315521

Locations: 🇺🇸
Texas Children's Hospital - Pavilion for Women, Houston, Texas, United States

DOXAZOSIN FOR PTSD

Phase 1

Completed

Conditions: PTSD

Interventions: Drug: doxazosin
Drug: Placebo
Drug: Perindopril

First Posted Date: 2014-12-04

Last Posted Date: 2022-04-26

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 30

Registration Number: NCT02308202

Locations: 🇺🇸
Baylor College of Medicine, Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy